Potassium Phosphate Monobasic
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09413 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 69 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | renal tubular acidosis | KG + DL |
| 2 | acute urate nephropathy | KG + DL |
| 3 | dyspepsia | KG + DL |
| 4 | potassium deficiency disease | KG + DL |
| 5 | nephrolithiasis | KG + DL |
| 6 | calcium-alkali syndrome | KG + DL |
| 7 | primary bone dysplasia with defective bone mineralization | KG + DL |
| 8 | obsolete vitamin D deficiency | KG + DL |
| 9 | renal osteodystrophy | KG + DL |
| 10 | exercise-induced malignant hyperthermia | KG + DL |
| 11 | Alstrom syndrome | KG + DL |
| 12 | hypophosphatemic rickets | KG + DL |
| 13 | impaired renal function disease | KG + DL |
| 14 | non-renal secondary hyperparathyroidism | KG + DL |
| 15 | hypophosphatemia (disease) | KG + DL |
| 16 | bone remodeling disease | KG + DL |
| 17 | gastroparesis (disease) | KG + DL |
| 18 | nephrolithiasis susceptibility caused by SLC26A1 | KG + DL |
| 19 | osteoporosis | KG + DL |
| 20 | hyperparathyroidism, transient neonatal | KG + DL |
| 21 | HELIX syndrome | KG + DL |
| 22 | Pendred syndrome | KG + DL |
| 23 | postmenopausal osteoporosis | KG + DL |
| 24 | hypocalcemic rickets | KG + DL |
| 25 | congenital prothrombin deficiency | KG + DL |
| 26 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
| 27 | hereditary hypophosphatemic rickets | KG + DL |
| 28 | developmental disability | KG + DL |
| 29 | pregnancy associated osteoporosis | KG + DL |
| 30 | Senior-Loken syndrome | KG + DL |
| 31 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 32 | urolithiasis | KG + DL |
| 33 | NAD(P)HX dehydratase deficiency | KG + DL |
| 34 | hypermanganesemia with dystonia | KG + DL |
| 35 | leukocyte adhesion deficiency | KG + DL |
| 36 | osteomalacia (disease) | KG + DL |
| 37 | autosomal recessive nonsyndromic deafness | KG + DL |
| 38 | familial visceral myopathy | KG + DL |
| 39 | rickets (disease) | KG + DL |
| 40 | vitamin D-dependent rickets | KG + DL |
| 41 | Fraser syndrome | KG + DL |
| 42 | human HOXA1 syndromes | KG + DL |
| 43 | malignant hyperthermia, susceptibility to | KG + DL |
| 44 | periodic paralysis (disease) | KG + DL |
| 45 | stomach disease | KG + DL |
| 46 | Worth syndrome | KG + DL |
| 47 | sulfur metabolism disease | KG + DL |
| 48 | King-Denborough syndrome | KG + DL |
| 49 | temtamy preaxial brachydactyly syndrome | KG + DL |
| 50 | bile duct disease | KG + DL |
(Showing top 50 of 69 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.